Skip to main content
SpringerLink
Log in

Multiple Sclerosis Pathology During Early and Late Disease Phases: Pathogenic and Clinical Relevance

  • Chapter
Immune Regulation and Immunotherapy in Autoimmune Disease

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aboul-Enein, F., Lassmann, H. (2005) Mitochondrial damage and histiotoxic hypoxia: a pathway of tissue injury in inflammatory brain disease. Acta Neuropathol. (Berl.) 109:49–55.

    Article  CAS  Google Scholar 

  • Aboul-Enein, F., Rauschka, H., Kornek, B., et al. (2003) Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases. J. Neuropathol. Exp. Neurol. 62(1):25–33.

    PubMed  CAS  Google Scholar 

  • Aktas, O., Smorodchenko, A., Brocke, S., Infante-Duarte, C., Topphoff, US., Vogt, J., Prozorovski, T., Meier, S., Osmanova, V., Pohl, E., Bechmann, I., Nitsch, R., Zipp, F. (2005) Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL. Neuron 46(3):421–432.

    Article  PubMed  CAS  Google Scholar 

  • Allen, I., McKeown, S. (1979) A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis. J. Neurosci. 41:81–91.

    CAS  Google Scholar 

  • Allen, I. V., Glover, G., Anderson, R. (1981) Abnormalities in the macroscopically normal white matter in cases of mild or spinal multiple sclerosis. Acta Neuropathol. (Berl.) Suppl 7:176–181.

    CAS  Google Scholar 

  • Allen, I. V., McQuaid, S., Mirakhur, M., Nevin, G. (2001) Pathological abnormalities in the normal-appearing white matter in multiple sclerosis. Neurol. Sci. 22(2):141–144.

    Article  PubMed  CAS  Google Scholar 

  • Amiry-Moghaddam, M., Otsuka, T., Hurn, P. D., et al. (2003) An alpha-syntrophin-dependent pool of AQP4 in astroglial end-feet confers bidirectional water flow between blood and brain. Proc. Natl. Acad. Sci. U S A 100(4):2106–2111.

    Article  PubMed  CAS  Google Scholar 

  • Andrews, H. E., Nichols, P. P., Bates, D., Turnbull, D. M. (2005) Mitochondrial dysfunction plays a key role in progressive axonal loss in multiple sclerosis. Med. Hypotheses 64:669–677.

    Article  PubMed  CAS  Google Scholar 

  • Anthony, D. C., Ferguson, M. K., Matyzak, K. M., et al. (1997) Differential matrix metalloproteinase expression in cases of MS and stroke. Neuropathol. Appl. Neurobiol. 23:406–415.

    Article  PubMed  CAS  Google Scholar 

  • Antony, J. M., van Marle, G., Opii, W., et al. (2004) Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendorcyte death and demyelination. Nat. Neurosci. 7:1088–1095.

    Article  PubMed  CAS  Google Scholar 

  • Babbe, H., Roers, A., Waisman, A., et al. (2000) Clonal expansion of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 192:393–404.

    Article  PubMed  CAS  Google Scholar 

  • Baranzini, S. E., Jeongk, M. C., Butunol C., et al. (1999) B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions. J. Immunol. 163:5133–5144.

    PubMed  CAS  Google Scholar 

  • Barnett, M. H., Prineas, J. W. (2004) Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann. Neurol. 55(4):458–468.

    Article  PubMed  Google Scholar 

  • Barres, B., Schmid, R., Sendtner, M., Raff, M. (1993) Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 118:283–295.

    PubMed  CAS  Google Scholar 

  • Bitsch, A., Bruhn, H., Vougioukas, V., et al. (1999) Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR Am. J. Neuroradiol. 20(9):1619–1627.

    PubMed  CAS  Google Scholar 

  • Bitsch, A., Kuhlmann, T., Da Costa, C., et al. (2000a) Tumour necrosis factor alpha mRNA expression in early multiple sclerosis lesions: correlation with demyelinating activity and oligodendrocyte pathology. Glia 29(4):366–375.

    Article  PubMed  CAS  Google Scholar 

  • Bitsch, A., Schuchardt, J., Bunkowski, S., et al. (2000b) Acute axonal injury in multiple sclerosis: correlation with demyelination and inflammation. Brain 123(Pt 6):1174–1183.

    Article  PubMed  Google Scholar 

  • Bo, L., Dawson, T., Wesselingh, S., et al. (1994) Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann. Neurol. 36:778–786.

    Article  PubMed  CAS  Google Scholar 

  • Bo, L., Vedeler, C., Nyland, H., et al. (2003a) Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult. Scler. 9(4):323–331.

    Article  PubMed  CAS  Google Scholar 

  • Bo, L., Vedeler, C., Nyland, H., et al. (2003b) Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J. Neuropathol. Exp. Neurol. 62(7):723–732.

    PubMed  Google Scholar 

  • Bolanos, J., Almeida, A., Stewart, V., et al. (1997) Nitric oxide-mediated mitochondrial damage in the brain: mechanisms and implications for neurodegenerative diseases. J. Neurochem. 68:2227–2240.

    PubMed  CAS  Google Scholar 

  • Bonetti, B., Pohl, J., Gao, Y. L., Raine, C. S. (1997) Cell death during autoimmune demyelination: effector but not target cells are eliminated by apoptosis. J. Immunol. 159(11):5733–5741.

    PubMed  CAS  Google Scholar 

  • Booss, J., Esiri, M. M., Tourtellotte, W. W., Mason, D. Y. (1983) Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. J. Neurol. Sci. 62:219–232.

    Article  PubMed  CAS  Google Scholar 

  • Boven, L. A., Van Meurs, M., Van Zwam, M., et al. (2006) Mylin-laden macropahges are anti-inflammatory consistent with foam cells in multiple sclerosis. Brain 129:517–526.

    Article  PubMed  Google Scholar 

  • Bozzali, M., Cercignani, M., Sormani, M. P., et al. (2002) Quantification of brain gray matter damage in different MS phenotypes by use of diffusion tensor MR imaging. AJNR Am. J. Neuroradiol. 23:985–988.

    PubMed  Google Scholar 

  • Brenner, T., Brocke, S., Szafer, F., et al. (1997) Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis. J. Immunol. 158:2940–2946.

    PubMed  CAS  Google Scholar 

  • Brown, G., Bolanos, J., Heales, S., Clark, J. (1995) Nitric oxide produced by activated astrocytes rapidly and reversibly inhibits cellular respiration. Neurosci. Lett. 193:201–204.

    Article  PubMed  CAS  Google Scholar 

  • Brown, G. C., Borutaite, V. (2002) Nitric oxide inhibition of mitochondrial respiration and its role in cell death. Free Radic. Biol. Med. 33:1440–1450.

    Article  PubMed  CAS  Google Scholar 

  • Bruck, W., Porada, P., Poser, S., et al. (1995) Monocyte-macrophage differentiation in early multiple sclerosis lesions. Ann. Neurol. 38:788–796.

    Article  PubMed  CAS  Google Scholar 

  • Brueck, W., Schmied, M., Suchanek, G., et al. (1994) Oligodendrocytes in the early course of multiple sclerosis. Ann. Neurol. 35:65–73.

    Article  Google Scholar 

  • Chang, A., Tourtellotte, W. W., Rudick, R., Trapp, B. D. (2002) Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N. Engl. J. Med. 346(3):165–173.

    Article  PubMed  Google Scholar 

  • Chen, C., Ro, L., Chang, C., et al. (1996) Serial MRI studies in pathologically verified Balo’s concentric sclerosis. J. Comput. Assist. Tomogr. 20:732–735.

    Article  PubMed  CAS  Google Scholar 

  • Christians, E. S., Yan, L. J., Benjamin, I. J. (2002) Heat shock factor 1 and heat shock proteins: critial partners in portection against acute cell injury. Crit. Care Med. 30:S43–S50.

    Article  CAS  Google Scholar 

  • Cifelli, A., Arridge, M., Jezzard, P., et al. (2002) Thalamic neurodegeneration in multiple sclerosis. Ann. Neurol. 52(5):650–653.

    Article  PubMed  Google Scholar 

  • Ciccarelli, O., Werring, D. J., Wheeler-Kingshott, C. A., et al. (2001) Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations. Neurology 56:926–933.

    PubMed  CAS  Google Scholar 

  • Coles, A. J., Wing, M. G., Molyneux, P., et al. (1999) Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis. Ann. Neurol. 46(3):296–304.

    Article  PubMed  CAS  Google Scholar 

  • Coles, A., Deans, J., Compston, A. (2004) Campath-1H treatment of multiple sclerosis: lessons from the bedside for the bench. Clin. Neurol. Neurosurg. 106(3):270–274.

    Article  PubMed  Google Scholar 

  • Confavreux, C., Vukusic, S., Moreau, T., Adeleine, P. (2000) Relapses and progression of disability in multiple sclerosis. N. Engl. J. Med. 343:1430–1438.

    Article  PubMed  CAS  Google Scholar 

  • Courville, C. (1970) Concentric sclerosis. In: Bruyn PVaG (ed) Handbood of Clinical Neurology. Amsterdam, Elsevier, pp 437–451.

    Google Scholar 

  • Cowden, W., Cullen, F., Staykova, M., Willenborg, D. (1998) Nitric oxide is a potential down-regulating molecule in autoimmune disease: inhibition of nitric oxide production renders PVG rats highly susceptible to EAE. J. Neuroimmunol. 88:1–8.

    Article  PubMed  CAS  Google Scholar 

  • Cox, A., Coles, A., Antoun, N., Malik, O., Lucchinnetti, C., Compston, A. (2005) Recurrent myelitis and optic neuritis in a 29-year-old woman. [Case Reports]. Clinical Conference. Lancet Neurology 4(8):510–516.

    Article  PubMed  Google Scholar 

  • Craner, M. J., Lo, A. C., Blcak, P. A., Wazxman, S. G. (2003) Abnormal sodium channel distribution in optic nerve axons in a model of inflammatory demyelination. Brain 126:1552–1561.

    Article  PubMed  Google Scholar 

  • Craner, M. J., Newcombe J., Black J. A., et al. (2004) Molecular changes in neurons in MS: altered axonal expression of Nav1.2 and Nav1.6 sodium channels and Na+/Ca++ exchanges. Proc. Natl. Am. Soc. USA 101:8168–8173.

    Article  CAS  Google Scholar 

  • Cross, A., Trotter, J., Lyons, J. (2001) B cells and antibodies in CNS demyelinating disease. J. Neuroimmunol. 112:1–14.

    Article  PubMed  CAS  Google Scholar 

  • Cuzner, M., Gveric, D., Strand, C. (1996) The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: comparison of stages in lesion evolution. J. Neuropathol. Exp. Neurol. 55:1194–1204.

    Article  PubMed  CAS  Google Scholar 

  • Dawson, J. (1916) The histology of dissseminated sclerosis. Trans. R. Soc. Edinb. 50:517–740.

    Google Scholar 

  • De Groot, C., Ruuls, S., Theeuwes, J., et al. (1997) Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 56:10–20.

    Article  PubMed  Google Scholar 

  • Dehmeshki, J., Chard, D. T., Leary, S. M., et al. (2003) The normal appearing grey matter in primary progressive multiple sclerosis: a magnetisation transfer imaging study. J. Neurol. 250:67–74.

    Article  PubMed  CAS  Google Scholar 

  • DeLuca, G. C., Ebers, G. C., Esiris, M. M. (2004) Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts. Brain 127:1009–1018.

    Article  PubMed  CAS  Google Scholar 

  • Diemel, L. T., Copelman, C. A., Cuzner, M. L. (1998) Macrophages in CNS remyelination: friend or foe? Neurochem. Res. 23(3):341–347.

    Article  PubMed  CAS  Google Scholar 

  • Dowling, P., Shang, G., Raval, S., et al. (1996) Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J. Exp. Med. 184(4):1513–1518.

    Article  PubMed  CAS  Google Scholar 

  • D’Souza, S., Bonetti, B., Balasingam, V., et al. (1996) Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J. Exp. Med. 184:2361–2370.

    Article  PubMed  Google Scholar 

  • Dutta, R., McDonough, J., Yin, X., et al. (2006) Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann. Neurol. 59:478–489.

    Article  PubMed  CAS  Google Scholar 

  • Esiri, M. M. (1977) Immunoglobulin-containing cells in multiple sclerosis plaques. Lancet 2:478.

    Article  PubMed  CAS  Google Scholar 

  • Evangelou, N. (2003) Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. Brain 2003;123:1845–1849.

    Article  Google Scholar 

  • Evangelou, N., Esiri, M. M., Smith, S., et al. (2000) Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann. Neurol. 47(3):391–395.

    Article  PubMed  CAS  Google Scholar 

  • Evangelou, N., Konz, D., Esiri, M. M., et al. (2001) Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. Brain 124:1813–1820.

    Article  PubMed  CAS  Google Scholar 

  • Ferguson, B., Matyszak, M. K., Esiri, M. M., Petty, V. H. (1997) Axonal damage in acute multiple sclerosis lesions. Brain 120:393–399.

    Article  PubMed  Google Scholar 

  • Filippi, M. (2003) Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis. Brain 126:433–437.

    Article  PubMed  CAS  Google Scholar 

  • Filippi, M., Campi, A., Dousset, V., et al. (1995) A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 45:478–482.

    PubMed  CAS  Google Scholar 

  • Filippi, M., Rocca, M., Martino, G., et al. (1998) Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann. Neurol. 43:809–814.

    Article  PubMed  CAS  Google Scholar 

  • Flavin, M. P., Coughlin, K., Ho, L. T. (1997) Soluble macrophage factors trigger apoptosis in cultured hippocampal neurons. Neuroscience 80:437–448.

    Article  PubMed  CAS  Google Scholar 

  • Flavin, M. P., Zhao, G., Ho, L. T. (2000) Microglial tissue plasminogen activator (tPA) triggers neuronal apoptosis in vitro. Glia 29:347–354.

    Article  PubMed  CAS  Google Scholar 

  • Foote, A. K., Blakemore, W. F. (2005) Inflammation stimulates remyelination in areas of chronic demyelination. Brain 128:528–539.

    Article  PubMed  CAS  Google Scholar 

  • Forstermann, U., Kleinert, H. (1995) Nitric oxide synthase: expression and expressional control of the three isoforms. Naunyn Schmiedebergs Arch. Pharmacol. 352:351–364.

    Article  PubMed  CAS  Google Scholar 

  • Franklin, R. J. (2002) Why does remyelination fail in multiple sclerosis? Nat. Rev. Neurosci. 3(9):705–714.

    Article  PubMed  CAS  Google Scholar 

  • Garbern, J., Spence, A., Alvord, E. (1986) Balo’s concentric demyelination diagnosed premortem. Neurology 36:1610–1614.

    PubMed  CAS  Google Scholar 

  • Garthwaite, G., Goodwin, D. A., Batchelor, A. M., et al. (2002) Nitric oxide toxicity in CNS white matter: an in vitro study using rat optic nerve. Neuroscience 109:145–155.

    Article  PubMed  CAS  Google Scholar 

  • Gay, F., Drye, T., Dick, G., Asiti, N. (1997) The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis: identification and characterization of primary demyelinating lesion. Brain 120:1461–1483.

    Article  PubMed  Google Scholar 

  • Genain, C. P., Cannella, B., Hauser, S. L., Raine, C. S. (1999) Identification of auto-antibodies associated with myelin damage in multiple sclerosis. Nat. Med. 5(2):170–175.

    Article  PubMed  CAS  Google Scholar 

  • Gendelman, H. E., Pezeshkpour, G. H., Pressman, N. J., et al. (1985) A quantitation of myelin-associated glycoprotein and myelin basic protein loss in different demyelinating diseases. Ann. Neurol. 18(3):324–328.

    Article  PubMed  CAS  Google Scholar 

  • Geurts, J. J., Wolswijk, G., Bo, L., et al. (2003) Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis. Brain 126:1755–1766.

    Article  PubMed  CAS  Google Scholar 

  • Gharagozloo, A., Poe, L., Collins, G. (1994) Antemortem diagnosis of Balo concentric sclerosis: correlative MR imaging and pathologic features. Radiology 191:817–819.

    PubMed  CAS  Google Scholar 

  • Gilgun-Sherki, Y., Panet, H., Melamed, E., Offen, D. (2003) Riluzole suppresses experimental autoimmune encephalomyelitis: implications for the treatment of multiple sclerosis. Brain Res. 989:196–204.

    Article  PubMed  CAS  Google Scholar 

  • Giovannoni, G., Heales, S., Land, J., Thompson, E. (1998) The potential role of nitric oxide in multiple sclerosis. Mult. Scler. 4:212–216.

    PubMed  CAS  Google Scholar 

  • Graumann, U., Reynolds, R., Steck, A. J., Schaeren-Wiemers, N. (2003) Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult. Brain Pathol. 13(4):554–573.

    PubMed  CAS  Google Scholar 

  • Griot, C., Vandevelde, M., Richard, A., et al. (1990) Selective degeneration of oligodendrocytes mediated by reactive oxygen species. Free Radic. Res. Commun. 11(4–5):181–193.

    Article  PubMed  CAS  Google Scholar 

  • Grossman, R. I., Braffman, B. H., Brorson, J. R., et al. (1988) Multiple sclerosis: serial study of gadolinium-enhanced MR imaging. Radiology 169:117–122.

    PubMed  CAS  Google Scholar 

  • Hafler, D. A. (2004) Multiple sclerosis. J. Clin. Invest. 113(6):788–794.

    PubMed  CAS  Google Scholar 

  • Hafler, D. A., Slavik, J. M., Anderson, D. E., et al. (2005) Multiple sclerosis. Immunol. Rev. 204:208–231.

    Article  PubMed  CAS  Google Scholar 

  • Hanemann, C., Kleinschmidt, A., Reifenberger, G., et al. (1993) Balo concentric sclerosis followed by MRI and positron emission tomography. Neuroradiology 35:578–580.

    Article  PubMed  CAS  Google Scholar 

  • Haring, J. S., Pewe, L. L., Perlman, S. (2002) Bystander CD8 T cell-mediated demyelination after viral infection of the central nervous system. J. Immunol. 169:1550–1555.

    PubMed  CAS  Google Scholar 

  • Hayashi, T., Burks, J. S., Hauser, S. L. (1988) Expression and cellular localization of major histocompatibility complex antigens in active multiple sclerosis lesions. Ann. N. Y. Acad. Sci. 540:301–305.

    Article  PubMed  CAS  Google Scholar 

  • Hendricks, J. J., Teunissen, C. E., de Vries, H. E., Dijkstra, C. D. (2005) Macrophages and neurodegeneration. Brain Res. Rev. 48:185–195.

    Article  CAS  Google Scholar 

  • Hill, K. E., Zollinger, L. V., Watt, H. E., et al. (2004) Inducible nitric oxide synthase in chronic active multiple sclerosis plaques: distribution, cellular expression, and association with myelin damage. J. Neuroimmunol. 151:171–179.

    Article  PubMed  CAS  Google Scholar 

  • Hoftberger, R., Aboul-Enein, F., Brueck, W., et al. (2004) Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions. Brain Pathol. 14:43–50.

    PubMed  CAS  Google Scholar 

  • Hohlfeld, R. (1997) Biotechnological agents for the immunotherapy of multiple sclerosis: principles, problems and perspectives. Brain 120:865–916.

    Article  PubMed  Google Scholar 

  • IFNB Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group. (1995) Interferon b-1b in the treatment of MS: final outcome of the randomized controlled trial. Neurology 45:1277–1285.

    Google Scholar 

  • Ingle, G. T., Stevenson, V. L., Miller, D. H., Thompson, A. J. (2003) Primary progressive multiple sclerosis: a 5-year clinical and MR study. Brain 126:2528–2536.

    Article  PubMed  CAS  Google Scholar 

  • Itoyama, Y., Sternberger, N. H., Webster, H. D., et al. (1980) Immunocytochemical observations on the distribution of myelin-associated glycoprotein and myelin basic protein in multiple sclerosis lesions. Ann. Neurol. 7:167–177.

    Article  PubMed  CAS  Google Scholar 

  • Itoyama, Y., Webster, H. D., Sternberger, N. H., et al. (1982) Distribution of papovavirus, myelin-associated glycoprotein, and myelin basic protein in progressive multifocal leukoencephalopathy lesions. Neurology 11(4):396–407.

    CAS  Google Scholar 

  • Jiang, F., Levison, S., Wood, T. (1999) Ciliary neurotrophic factor induces expression of the IGF type I receptor and FGF receptor 1 mRNAs in adult rat brain oligodendrocytes. J. Neurosci. Res. 57:447–457.

    Article  PubMed  CAS  Google Scholar 

  • Jung, J., Bhat, R., Preston, G., et al. (1994) Molecular characterization of an aquaporin cDNA from brain: candidate osmoreceptor and regulator of water balance. Proc. Natl. Acad. Sci. USA 91:13052–13056.

    Article  PubMed  CAS  Google Scholar 

  • Jurewicz, A., Biddison, W. E., Antel, J. P. (1998) MHC class I-restricted lysis of human oligodendrocytes by myelin basic protein peptide-specific CD8 T lymphocytes. J. Immunol. 160:3056–3059.

    PubMed  CAS  Google Scholar 

  • Kapoor, R., Davies, M., Blaker, P., et al. (2003) Blockers of sodium and calcium entry protect axons from nitric-oxide medaited degeneration. Ann. Neurol. 53(2):174–180.

    Article  PubMed  CAS  Google Scholar 

  • Karaarslan, E., Altintas, A., Senol, U., et al. (2001) Balo’s concentric sclerosis: clinical and radiologic features of five cases. AJNR Am. J. Neuroradiol. 22(7):1362–1367.

    PubMed  CAS  Google Scholar 

  • Keegan, M., Konig, F., McClelland, R., et al. (2005) Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange. Lancet 2005;366(9485):579–582.

    Article  PubMed  Google Scholar 

  • Kerschensteiner, M., Gallmeier, E., Behrens, L., et al. (1999) Activated human T cells, B cells and monocytes produce brain-derived neurotrophic factor (BDNF) in vitro and in brain lesions: a neuroprotective role for inflammation? J. Exp. Med. 189:865–870.

    Article  PubMed  CAS  Google Scholar 

  • Kidd, D., Barkhof, F., McConnell, R., et al. (1999) Cortical lesions in multiple sclerosis. Brain 122(1):17–26.

    Article  PubMed  Google Scholar 

  • Kivisakk, P., Mahad, D., Callahan, M. K., et al. (2003) Cerebrospinal fluid central memory T-cells traffic through choroid plexus and meninges. Proc. Natl. Acad. Sci. U S A 100:8389–8394.

    Article  PubMed  CAS  Google Scholar 

  • Kornek, B., Lassmann, H. (1999) Axonal pathology in multiple sclerosis: a historical note. Brain Pathol. 9:651–656.

    Article  PubMed  CAS  Google Scholar 

  • Kornek, B., Storch, M. K., Weissert, R., et al. (2000) Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am. J. Pathol. 157(1):267–276.

    PubMed  CAS  Google Scholar 

  • Korte, J., Born, E., Vos, L., et al. (1994) Balo concentric sclerosis: MR diagnosis. AJNR Am. J. Neuroradiol. 15:1284–1285.

    PubMed  CAS  Google Scholar 

  • Kotter, M. R., Setzu, A., Sim, F. J., et al. (2001) Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination. Glia 35(3):204–212.

    Article  PubMed  CAS  Google Scholar 

  • Kuroiwa, Y. (1982) Clinical and epidemiological aspects of multiple sclerosis in Japan. Jpn. J. Med. 21(2):135–140.

    PubMed  CAS  Google Scholar 

  • Kutzelnigg, A., Lucchinetti, C., Stadelmann, C., et al. (2005) Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128(11):2705–2712.

    Article  PubMed  Google Scholar 

  • Lassmann, H. (1983) Comparative neuropathology of chronic experimental allergic encephalomyelitis and mulitple sclerosis. Springer Schriftenr. Neurol. 25:1–135.

    CAS  Google Scholar 

  • Lassmann, H. (2003a) Hypoxia-like tissue injury as a component of multiple sclerosis lesions. J. Neurol. Sci. 206(2):187–191.

    Article  PubMed  CAS  Google Scholar 

  • Lassmann, H. (2003b) Axonal injury in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 74:695–697.

    Article  PubMed  CAS  Google Scholar 

  • Lassmann, H., Wisniewski, H. M. (1979) Chronic relapsing experimental allergic encephalomyelitis: morphological sequence of myelin degradation. Brain Res. 169:357–368.

    Article  PubMed  CAS  Google Scholar 

  • Lennon, V. A., Wingerchuk, D. M., Kryzer, T. J., et al. (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106–2112.

    Article  PubMed  CAS  Google Scholar 

  • Lennon, V. A., Kryzer, T. J., Pittock, S. J., et al. (2005) IgG marker of optic-spinal MS binds to the aquaporin 4 water channel. J. Exp. Med. 202(4):473–477.

    Article  PubMed  CAS  Google Scholar 

  • Linberg, R. L., De Groot, C. J., Montagne, L., et al. (2001) The expression profile of matrix metalloproteinases and their inhibitors in lesions and normal appearing white matter of multiple sclerosis. Brain 124:1743–1753.

    Article  Google Scholar 

  • Linington, C., Bradl, M., Lassmann, H., et al. (1988) Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am. J. Pathol. 130:443–454.

    PubMed  CAS  Google Scholar 

  • Liu, J., Zhao, M., Brosnan, C., Lee, S. (2001) Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. Am. J. Pathol. 158:2057–2066.

    PubMed  CAS  Google Scholar 

  • Lock, C., Hermans, G., Pedotti, R., et al. (2002) Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8:500–508.

    Article  PubMed  CAS  Google Scholar 

  • Louis, J., Magal, E., Takayama, S., Varon, S. (1993) CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science 259:689–692.

    Article  PubMed  CAS  Google Scholar 

  • Lu, F., Selak, M., O’Connor, J., et al. (2000) Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J. Neurol. Sci. 177:95–103.

    Article  PubMed  CAS  Google Scholar 

  • Lu, W., Bhasin, M., Tsirka, S. E. (2002) Involvment of tissue plasminogen activator in onset and effector phases of experimental allergic encpehalomyelitis. J. Neurosci. 22:10781–10789.

    PubMed  CAS  Google Scholar 

  • Lublin, F. D., Baier, M., Cutter, G. (2003) Effect of relapses on development of residual deficit in multiple sclerosis. Neurology 61:1528–1532.

    PubMed  Google Scholar 

  • Lucchinetti C., Bruck W. (2004) The pathology of primary progressive multiple sclerosis. Mult. Scler. 10(Suppl 1):S23–S30.

    Article  PubMed  Google Scholar 

  • Lucchinetti, C. F., Brueck, W., Rodriguez, M., et al. (1999) A quantitative study on the fate of the oligodendrocyte in multiple sclerosis lesions: a study of 113 cases. Brain 122:2279–2295.

    Article  PubMed  Google Scholar 

  • Lucchinetti, C. F., Bruck, W., Parisi, J., et al. (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 47:707–717.

    Article  PubMed  CAS  Google Scholar 

  • Lucchinetti, C. F., Mandler, R. N., McGavern, D., et al. (2002a) A role for humoral mechanisms in the pathogenesis of Devic’s neuromyelitis optica. Brain 125(Pt 7):1450–1461.

    Article  PubMed  Google Scholar 

  • Lucchinetti, C., Mandler, R., Weinshenker, B., et al. (2002b) Humoral mechanisms in the pathogenesis of Devic’s neuromyelitis optica. Neurology 54(Suppl 3):A259.

    Google Scholar 

  • Lucchinetti, C. F., Bruck, W., Lassmann, H. (2004) Evidence for pathogenic heterogeneity in multiple sclerosis. Ann. Neurol. 56:308.

    Article  PubMed  Google Scholar 

  • Ludwin, S., Johnson, E. (1981) Evidence of a “dying back” gliopathy in demyelinating disease. Ann. Neurol. 9:301–305.

    Article  PubMed  CAS  Google Scholar 

  • Ludwin, S. K. (1990) Oligodendrocyte survival in wallerian degeneration. Acta Neuropathol. (Berl.) 80:184–191.

    Article  CAS  Google Scholar 

  • Lumsden, C. (1970) The neuropathology of multiple sclerosis. In: Vinken P, Bruyn G (eds) Handbook of Clinical Neurology. New York, Elsevier, pp 217–309.

    Google Scholar 

  • Mahad, D. J., Trebst, C., Kivisakk, P., et al. (2004) Expression of chemokine receptors CCR1 and CCR5 reflects differential activation of mononuclear phagocytes in pattern II and pattern III multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 63(3):262–273.

    PubMed  CAS  Google Scholar 

  • Mantovani, A., Sica, A., Sozzani, S., et al. (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25:677–686.

    Article  PubMed  CAS  Google Scholar 

  • Marburg, O. (1906) Die sogenannte “akute Multiple Sklerose”. J. Psychiatr. Neurol. 27:211–312.

    Google Scholar 

  • Matute, C., Alberdi, E., Domercq, M., et al. (2001) The link between excitotoxic oligodendroglial death and demyelinating diseases. Trends Neurosci. 24(4):224–230.

    Article  PubMed  CAS  Google Scholar 

  • Mayer, M., Bhakoo, K., Noble, M. (1994) Ciliary Neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro. Development 120:143–153.

    PubMed  CAS  Google Scholar 

  • McCombe, P. A., Nickson, I., Tabi, Z., Pender, M. P. (1996) Corticosteroid treatment of experimental autoimmune encephalomyelitis in the Lewis rat results in loss of V beta 8.2+ and myelin basic protein-reactive cells from the spinal cord, with increased total T-cell apoptosis but reduced apoptosis of V beta 8.2+ cells. J. Neuroimmunol. 70(2):93–101.

    Article  PubMed  CAS  Google Scholar 

  • McKeown, S. R., Allen, V. (1978) The cellular origin of lysosomal enzymes in the plaque of multiple sclerosis: a combined histological and biochemical study. Neuropathol. Appl. Neurobiol. 4:471–482.

    Article  CAS  Google Scholar 

  • Mehta, P. D., et al. (1981) Bound antibody in multiple sclerosis brains. J. Neurol. Sci. 49:91–98.

    Article  PubMed  CAS  Google Scholar 

  • Merrill, J. E., Scolding, N. J. (1999) Mechanisms of damage to myelin and oligodendrocytes and their relevance to disease. Neuropathol. Appl. Neurobiol. 25(6):435–458.

    Article  CAS  Google Scholar 

  • Mews, I., Bergmann, M., Bunkowski, S., et al. (1998) Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions. Mult. Scler. 4(2):55–62.

    PubMed  CAS  Google Scholar 

  • Miller, D. H., Rudge, P., Johnson, G., et al. (1988) Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain 111:927–939.

    Article  PubMed  Google Scholar 

  • Moalem, G., Leibowitz-Amit, R., Yoles, E., et al. (1999) Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat. Med. 5(1):49–55.

    Article  PubMed  CAS  Google Scholar 

  • Molyneux, P. D., Kappos, L., Polman, C., et al. (2000) The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis: European Study Group on interferon beta-1b in secondary progressive multiple sclerosis. Brain 123(Pt 11):2256–2263.

    Article  PubMed  Google Scholar 

  • Mosser, D. M. (2003) The many faces of macrophage activation. J. Leukoc. Biol. 73:209–212.

    Article  PubMed  CAS  Google Scholar 

  • Murray, P., McGavern, D., Lin, X., et al. (1998) Perforin-dependent neurologic injury in a viral model of multiple sclerosis. J. Neurosci. 18:7306–7314.

    PubMed  CAS  Google Scholar 

  • Neumann, H., Medana, I. M., Bauer, J., Lassmann, H. (2002) Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci. 25(6):313–319.

    Article  PubMed  CAS  Google Scholar 

  • Nitsch, R., Pohl, E. E., Smorodchenko, A., Infante-Duarte, C., Aktas, O., Zipp, F. (2004) Direct impact of T cells on neurons revealed by two-photon microscopy in living brain tissue. Journal of Neuroscience 24(10):2458–2464.

    Article  PubMed  CAS  Google Scholar 

  • Oleszak, E. L., Zaczynska, E., Bhattacharjee, M., et al. (1998) Indcible nitric oxide synthase and nitrotyrosine are dound in monocytes/macropahges and/or astrocytes in acute, but not in chronic multiple sclerosis. Clin. Diagn. Lab. Immunol. 5:438–445.

    PubMed  CAS  Google Scholar 

  • Onodera, H., Nakashima, I., Fujihara, K., et al. (1999) Elevated plasma level of plasminogen activator inhibitor-1 (PAI01) in patients with relapsing-remitting multiple sclerosis. Tohoku J. Exp. Med. 189:259–265.

    Article  PubMed  CAS  Google Scholar 

  • Owens, G. P., Kraus H., Burgoon, M. P., et al. (1998) Restricted use of VH4 germline segments in an acute multiple sclerosis brain. Ann. Neurol. 43:236–243.

    Article  PubMed  CAS  Google Scholar 

  • Owens, G. P., Ritchie, A. M., Burgoon, M. P., et al. (2003) Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal flu. J. Immunol. 171:2725–2733.

    PubMed  CAS  Google Scholar 

  • Ozawa, K., Suchanek, G., Breitschopf, H., et al. (1994) Patterns of oligodendroglia pathology in multiple sclerosis. Brain 117:1311–1322.

    Article  PubMed  Google Scholar 

  • Pelletier, D., Nelson, S. J., Oh, J., et al. (2003) MRI lesion volume heterogeneity in primary progressive MS in relation with axonal damage and brain atrophy. J. Neurol. Neurosurg. Psychiatry 74:950–952.

    Article  PubMed  CAS  Google Scholar 

  • Peterson, J. W., Bo, L., Mork, S., et al. (2001) Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann. Neurol. 50(3):389–400.

    Article  PubMed  CAS  Google Scholar 

  • Pitt, D., Werner, P., Raine, C. S. (2000) Glutamate excitotoxicity in a model of multiple sclerosis. Nat. Med. 6(1):67–70.

    Article  PubMed  CAS  Google Scholar 

  • Pittock, S. J., Mayr, W. T., McClelland, R. L., et al. (2004) Change in MS-related disability in a population-based cohort: a 10-year follow-up study. Neurology 62(1):51–59.

    PubMed  CAS  Google Scholar 

  • Pittock, S. J., McClelland, R. L., Achenbach, S. J. The neuroimmunology of multiple sclerosis: possible roles of T and B lymphocytes in immunopathogenesis, et al. (2005) Clinical course, pathologic correlations and outcome of biopsy proven inflammatory demyelinating disease. J. Neurol. Neurosurg. Psychiatry 767(12):1693–1697.

    Article  Google Scholar 

  • Pittock, S. J., Lennon, V. A., Krecke, K., et al. (2006) Brain abnormalities in patients with neuromyelitis optica. Arch. Neurol. 63:390–396.

    Article  PubMed  Google Scholar 

  • Prat, A., Antel, J. (2005) Pathogenesis of multiple sclerosis. Curr. Opin. Neurol. 18:225–230.

    Article  PubMed  CAS  Google Scholar 

  • Prineas, J. (1985) The neuropathology of multiple sclerosis. In: Vinken P, Bruyn G, Klawans H (eds) Handbook of Clinical Neurology. New York, Elsevier Science, pp 213–257.

    Google Scholar 

  • Prineas, J. W., Graham, J. S. (1981) Multiple sclerosis: capping of surface immunoglobulin G on macrophages engaged in myelin breakdown. Ann. Neurol. 10:149–158.

    Article  PubMed  CAS  Google Scholar 

  • Prineas, J. W., Wright, R. G. (1978) Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab. Invest. 38(4):409–421.

    PubMed  CAS  Google Scholar 

  • Prineas, J. W., Barnard, R. O., Kwon, E. E., et al. (1992a) Multiple sclerosis: remyelination of nascent lesions. Ann. Neurol. 33:137–151.

    Article  Google Scholar 

  • Prineas, J. W., Barnard, R. O., Revesz, T., et al. (1992b) Multiple sclerosis: pathology of recurrent lesions. Brain 116(Pt 3):681–693.

    Google Scholar 

  • Prineas, J. W., Kwon, E. E., Cho, E. S., et al. (2001) Immunopathology of secondary-progressive multiple sclerosis. Ann. Neurol. 50(5):646–657.

    Article  PubMed  CAS  Google Scholar 

  • Probert, L., Akassoglou, K., Pasparakis, M., et al. (1995) Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha. Proc. Natl. Acad. Sci. USA 92:11294–11298.

    Article  PubMed  CAS  Google Scholar 

  • Qin, Y., et al. (1998) Clonal expansion and somatic hypermutation of V (H) genes of B cells from cerebrospinal fluid in multiple sclerosis. J. Clin. Invest. 102:1045–1050.

    Article  PubMed  CAS  Google Scholar 

  • Raine, C. S., Scheinberg, L., Waltz, J. M. (1981) Multiple sclerosis: oligodendrocyte survival and proliferation in an active established lesion. Lab. Invest. 45:534–546.

    PubMed  CAS  Google Scholar 

  • Raine, C. S., Cannella, B., Duijvestijn, A. M., Cross, A. H. (1990) Homing to central nervous system vasculature by antigen-specific lymphocytes. II. Lymphocyte/endothelial cell adhesion during the initial stages of autoimmune demyelination. Lab. Invest. 63:476–489.

    PubMed  CAS  Google Scholar 

  • Redford, E. J., Kapoor, R., Smith, K. J. (1997) Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. Brain 120:2149–2157.

    Article  PubMed  Google Scholar 

  • Revel, M., Valiente, E., Gray, F., et al. (1993) Concentric MR patterns in multiple sclerosis: report of two cases. J. Neuroradiol. 20(4):252–257.

    PubMed  CAS  Google Scholar 

  • Rivera-Quinones, C., McGavern, D., Schmelzer, J. D., et al. (1998) Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis. Nat. Med. 4(2):187–193.

    Article  PubMed  CAS  Google Scholar 

  • Rocca, M. A., Iannucci, G., Rovaris, M., et al. (2003) Occult tissue damage in patients with primary progressive multiple sclerosis is independent of T2-visible lesions: a diffusion tensor MR study. J. Neurol. 250:456–460.

    Article  PubMed  Google Scholar 

  • Rodriguez, M. (1985) Virus-induced demyelination in mice: “dying back” of oligodendrocytes. Mayo Clin. Proc. 60:433–438.

    PubMed  CAS  Google Scholar 

  • Rodriguez, M., Sheithauer, B. (1994) Ultrastructure of multiple sclerosis. Ultrastruct. Pathol. 18:3–13.

    Article  PubMed  CAS  Google Scholar 

  • Rotola, A., Merlotti, I., Caniatti, L., et al. (2004) Human herpesvirus 6 infects the central nervous system of multiple sclerosis patients in the early stages of the disease. Mult. Scler. 10:348–354.

    Article  PubMed  CAS  Google Scholar 

  • Rovaris, M., Bozzali, M., Santuccio, G., et al. (2001) In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis. Brain 124:2540–2549.

    Article  PubMed  CAS  Google Scholar 

  • Rovaris, M., Bozzali, M., Iannucci, G., et al. (2002) Assessment of normal-appearing white and gray matter in patients with primary progressive multiple sclerosis: a diffusion-tensor magnetic resonance imaging study. Arch. Neurol. 59:1406–1412.

    Article  PubMed  Google Scholar 

  • Sadahiro, S., Yoshikawa, H., Yagi, N., et al. (2000) Morphometric analysis of the myelin-associated oligodendrocytic basic protein-deficient mouse reveals a possible role for myelin-associated oligodendrocytic basic protein in regulating axonal diameter. Neuroscience 98(2):361–367.

    Article  PubMed  CAS  Google Scholar 

  • Scolding, N. J., Jones, J., Compston, D. A., Morgan, B. P. (1990) Oligodendrocyte susceptibility to injury by T-cell perforin. Immunology 70:6–10.

    PubMed  CAS  Google Scholar 

  • Selmaj, K. W., Raine, C. S. (1988) Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23:339–346.

    Article  PubMed  CAS  Google Scholar 

  • Selmaj, K., Brosnan, C. F., Raine, C. S. (1991a) Colocalization of lymphocytes bearing gamma delta T-cell receptor and heat shock protein hsp65+ oligodendrocytes in multiple sclerosis. Proc. Natl. Acad. Sci. USA 88:6452–6456.

    Article  PubMed  CAS  Google Scholar 

  • Selmaj, K., Cross, A. H., Farooq, M., et al. (1991b) Non-specific oligodendrocyte cytotoxicity mediated by soluble products of activated T cell lines. J. Neuroimmunol. 35:261–271.

    Article  PubMed  CAS  Google Scholar 

  • Selmaj, K., Raine, C. S., Cannella, B., Brosnan, C. F. (1991c) Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 87:949–954.

    Article  PubMed  CAS  Google Scholar 

  • Selmaj, K., Brosnan, C. F., Raine, C. S. (1992) Expression of heat shock protein-65 by oligodendrocytes in vivo and in vitro: implications for multiple sclerosis. Neurology 42:795–800.

    PubMed  CAS  Google Scholar 

  • Sendtner, M., Carroll, P., Holtmann, B., et al. (1994) Ciliary neurotrophic factor. J. Neurobiol. 25:1436–1453.

    Article  PubMed  CAS  Google Scholar 

  • Sharp, F. R., Bernaudin, M. (2004) HIF1 and oxygen sensing in the brain. Nat. Rev. Neurosci. 5:437–448.

    Article  PubMed  CAS  Google Scholar 

  • Skulina, C., Schmidt, S., Dornmair, K., et al. (2004) Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc. Natl. Acad. Sci. USA 101:2428.

    Article  PubMed  CAS  Google Scholar 

  • Smith, K. J., Lassmann, H. (2002) The role of nitric oxide in multiple sclerosis. Lancet Neurol. 1(4):232–241.

    Article  PubMed  CAS  Google Scholar 

  • Smith, K. J., Kapoor, R., Hall, S. M., Davies, M. (2001) Electrically active axons degenerate when exposed to nitric oxide. Ann. Neurol. 49(4):470–476.

    Article  PubMed  CAS  Google Scholar 

  • Smith, T., Groom, A., Zhu, B., Turski, L. (2000) Autoimmune encephalomyelitis ameliorated by AMPA antagonists. Nat. Med. 6(1):62–66.

    Article  PubMed  CAS  Google Scholar 

  • Smith-Jensen, T., Burgoon, M. P., Anthony, J., et al. (2000) Comparison of immunoglobulin G heavy-chain sequences in MS and SSPE brains reveals an antigen-driven response. Neurology 54:1227–1232.

    PubMed  CAS  Google Scholar 

  • Sobel, R., Mitchell, M., Fondren, G. (1990) Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system. Am. J. Pathol. 136:1309–1316.

    PubMed  CAS  Google Scholar 

  • Spiegel, M., Kruger, H., Hofmann, E., Kappos, L. (1989) MRI study of Balo’s concentric sclerosis before and after immunosuppressant therapy. J. Neurol. 236:487–488.

    Article  PubMed  CAS  Google Scholar 

  • Stadelmann, C., Kerschensteiner, M., Misgeld, T., et al. (2002) BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune cells and neuronal cells. Brain 125:75–85.

    Article  PubMed  Google Scholar 

  • Stadelmann, C., Ludwin, S. K., Tabira, T., et al. (2004) Hypoxic preconditioning explains concentric lesions in Balo’s type of multiple sclerosis. Submitted.

    Google Scholar 

  • Stadelmann, C., Ludwin, S., Tabira, T., Guseo, A., Lucchinetti, C. F., Leel-Ossy, L., Ordinario, A. T., Bruck, W., Lassmann, H. (2005) Tissue preconditioning may explain concentric lesion in Balo’s type of multiple sclerosis. Brain 128(Pt 5):979–987.

    Article  PubMed  Google Scholar 

  • Storch, M. K., Piddlesden, S., Haltia, M., et al. (1998) Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination. Ann. Neurol. 43(4):465–471.

    Article  PubMed  CAS  Google Scholar 

  • Stys, P. K. (2004) Axonal degeneration in multiple sclerosis: is it time for neuroprotective strategies? Ann. Neurol. 55:601–603.

    Article  PubMed  CAS  Google Scholar 

  • Thompson, A., Kermode, A., Wicks, D., et al. (1991) Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann. Neurol. 29:53–62.

    Article  PubMed  CAS  Google Scholar 

  • Thompson, A. J., Polman, C. H., Miller, D. H., et al. (1997) Primary progressive multiple sclerosis. Brain 120:1085–1096.

    Article  PubMed  Google Scholar 

  • Trapp, B. D., Peterson, J., Ransohoff, R. M., et al. (1998) Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338:278–285.

    Article  PubMed  CAS  Google Scholar 

  • Traugott, U. (1983) Multiple sclerosis: relevance of class I and class II MHC-expressing cells to lesion development. J. Neuroimmunol. 16:283–302.

    Article  Google Scholar 

  • Trebst, C., Sorensen, T., Kivisakk, P., et al. (2001) CCR1+/CCRf+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis. Am. J. Pathol. 159:1701–1710.

    PubMed  CAS  Google Scholar 

  • Van der Goes, A., Boorsma, W., Hoekstra, K., et al. (2005) Determination of the sequential degradation of myelin proteins by macrophages. J. Neuroimmunol. 161:12–20.

    Article  PubMed  CAS  Google Scholar 

  • Vass, K., Welch, W. J., Nowak, T. S. (1988) Localization of 70-kDa stress protein induction in gerbil brain after ischemia. Acta Neuropathol. (Berl.) 77:128–135.

    CAS  Google Scholar 

  • Vercellino, M., Plano, F., Votta, B., et al. (2005) Grey matter pathology in multiple sclerosis. J. Neuropathol. Exp. Neurol. 64(12):1101–1107.

    Article  PubMed  Google Scholar 

  • Vos, C. M., van Haastert, E. S., De Groot, C. J., et al. (2003) Matrix metalloproteinase-12 is expressed in phagocytotic macrophages in active multiple sclerosis lesions. J. Neuroimmunol. 138:106–114.

    Article  PubMed  CAS  Google Scholar 

  • Werner, P., Pitt, D., Raine, C. S. (2001) Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann. Neurol. 50(2):169–180.

    Article  PubMed  CAS  Google Scholar 

  • Williamson, R. A., Burgoon, M. P., Owens, G. P., et al. (2001) Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis. Proc. Natl. Acad. Sci. USA 2001;98:1793–1798.

    Article  PubMed  CAS  Google Scholar 

  • Wingerchuk, D. M., Hogancamp, W. F., O’Brien, P. C., Weinshenker, B. G. (1999) The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology 53(5):1107–1114.

    PubMed  CAS  Google Scholar 

  • Wingerchuk, D., Pittock, S., Lennon, V., et al. (2005) Neuromyelitis optica diagnostic criteria revisited: validation and incorporation of the NMO-IgG serum autoantibody. Neurology 64:A38.

    Google Scholar 

  • Wolswijk, G. (1998) Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J. Neurosci. 18(2):601–609.

    PubMed  CAS  Google Scholar 

  • Yamashita, T., Ando, Y., Obayashi, K., et al. (1997) Changes in nitrite and nitrate (NO2 -/NO3 -) levels in cerebrospinal fluid of patients with multiple sclerosis. J. Neurol. Sci. 153:32–34.

    Article  PubMed  CAS  Google Scholar 

  • Yao, D. L., Webster, H., Hudson, L. D., et al. (1994) Concentric sclerosis (Balo): morphometric and in situ hybridization study of lesions in six patients. Ann. Neurol. 35:18–30.

    Article  PubMed  CAS  Google Scholar 

  • Yoshikawa, H. (2001) Myelin-associated oligodendrocytic basic protein modulates the arrangement of radial growth of the axon and the radial component of myelin. Med. Electron Microsc. 34(3):160–164.

    Article  PubMed  CAS  Google Scholar 

  • Youl, B. D., Kermode, A. G., Thompson, A. J., et al. (1991) Destructive lesions in demyelinating disease. J. Neurol. Neurosurg. Psychiatry 54:288–292.

    Article  PubMed  CAS  Google Scholar 

  • Zhao, W., Tilton, R. G., Corbett, J. A., et al. (1996) Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase. J. Neuroimmunol. 64:123–133.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN, USA

    Claudia F. Lucchinetti

Authors
  1. Claudia F. Lucchinetti
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Shanghai JiaoTong University School of Medicine, Shanghai, China

    Jingwu Zhang M.D., Ph.D.

  2. Baylor College of Medicine, Houston, Texas, USA

    Jingwu Zhang M.D., Ph.D.

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Lucchinetti, C.F. (2007). Multiple Sclerosis Pathology During Early and Late Disease Phases: Pathogenic and Clinical Relevance. In: Zhang, J. (eds) Immune Regulation and Immunotherapy in Autoimmune Disease. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-36003-4_12

Download citation

Publish with us

Policies and ethics

Search

Navigation